Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Qiagen NV's Enterprise Value is €9,187 Mil.
Qiagen NV's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €448 Mil. Therefore, Qiagen NV's EV-to-EBIT ratio for today is 20.50.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Qiagen NV's Enterprise Value is €9,187 Mil.
Qiagen NV's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €594 Mil. Therefore, Qiagen NV's EV-to-EBITDA ratio for today is 15.47.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Qiagen NV's Enterprise Value is €9,187 Mil.
Qiagen NV's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €1,823 Mil. Therefore, Qiagen NV's EV-to-Revenue ratio for today is 5.04.
Qiagen NV Enterprise Value Historical Data
The historical data trend for Qiagen NV's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Qiagen NV's Enterprise Value
For the Diagnostics & Research subindustry, Qiagen NV's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qiagen NV's Enterprise Value Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Qiagen NV's Enterprise Value falls into.
Qiagen NV Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Qiagen NV's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qiagen NV (XTER:QIA) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Qiagen NV's current Enterprise Value is €9,187 Mil.
Qiagen NV's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €448 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Qiagen NV's current Enterprise Value is €9,187 Mil.
Qiagen NV's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €594 Mil.
Qiagen NV's current Enterprise Value is €9,187 Mil.
Qiagen NV's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,823 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qiagen NV Enterprise Value Related Terms
Thank you for viewing the detailed overview of Qiagen NV's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:QIA has been successfully added to your 